Stock NEOPHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

NeoPharm Co., Ltd. Share Price Korea S.E.

Equities

Personal Products

End-of-day quote Korea S.E.
Other stock markets
- - Intraday chart for NeoPharm Co., Ltd.
2023 NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2019 NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding CI

Financials

Sales 2024 * 120B 87.36M 0 7B Sales 2025 * 145B 106M 0 8.45B Capitalization 205B 149M 0 11.92B
Net income 2024 * 23B 16.74M - 1.34B Net income 2025 * 30B 21.84M - 1.75B EV / Sales 2024 * 0.63 x
Net cash position 2024 * 128B 93.48M 0 7.49B Net cash position 2025 * 152B 111M 0 8.89B EV / Sales 2025 * 0.36 x
P/E ratio 2024 *
9.3 x
P/E ratio 2025 *
7.09 x
Employees -
Yield 2024 *
2.88%
Yield 2025 *
2.88%
Free-Float 56.96%
More Fundamentals * Assessed data

Latest news about NeoPharm Co., Ltd.

NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding CI
NeoPharm CO., LTD. announced that it expects to receive KRW 31.970667276 billion in funding CI
Gpower, inc. cancelled the acquisition of 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park. CI
Gpower, inc. agreed to acquire 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park for approximately KRW 780 million. CI
HOPE BIOSCIENCES, INC. Acquires Worldwide Rights to Novel MERTK/AXL Inhibitor from Neopharm Co. Ltd CI
Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan and 7 individuals. CI
Han Bul Cosmetics Co., Ltd. and an individual signed a contract to acquire 29.39% stake in Neopharm Co Ltd from Yong-Chan Ahn and 7 individuals for KRW 72.8 billion. CI
Neopharm Co Ltd(KOSDAQ:A092730) added to S&P Global BMI Index CI
LEO Pharma A/S Enters Supply and Distribution Agreement with NeoPharm Co., Ltd. on Non-Prescription Skin Care Solutions CI
Neopharm Co Ltd's Equity Buyback announced on February 10, 2014 has expired. CI
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014. CI
Neopharm Co Ltd authorizes a Buyback Plan. CI
Neopharm Co Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares. CI
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on July 9, 2013 CI
More news

Managers and Directors - NeoPharm Co., Ltd.

Managers TitleAgeSince
Yang-Soo Kim CEO
 Chief Executive Officer 54 31/07/12
Yoon Kim CTO
 Chief Tech/Sci/R&D Officer 59 30/06/00
Woo-Jae Lim BRD
 Director/Board Member 45 24/03/21
Members of the board TitleAgeSince
Yoon Kim CTO
 Chief Tech/Sci/R&D Officer 59 30/06/00
Dong-Jin Choi BRD
 Director/Board Member 64 20/03/19
Yang-Soo Kim CEO
 Chief Executive Officer 54 31/07/12
More insiders

Company Profile

NeoPharm Co., Ltd. is a Korea-based company engaged in the manufacture of cosmetics. The Company produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. It also engages in the original equipment manufacturing (OEM) of skin drugs.
Sector
Personal Products
Calendar
09/05/2024 - Q1 2024 Earnings Release (Projected)
More about the company

Sector Cosmetics & Perfumes

1st Jan change Capi.
L'ORÉAL Stock L'Oréal
-3.30% 251B
KAO CORPORATION Stock Kao Corporation
+12.81% 19.44B
GALDERMA GROUP AG Stock Galderma Group AG
0.00% 17.73B
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
+0.38% 11.04B
COTY INC. Stock Coty Inc.
-8.45% 10.11B
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+16.90% 7.51B
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+10.15% 5.97B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
+0.12% 4.42B
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-18.99% 3.7B
Cosmetics & Perfumes
  1. Stock Market
  2. Equities
  3. A092730 Stock
  4. Stock